Stocks and InvestingStocks and Investing
Tue, December 12, 2023
Mon, December 11, 2023
Sun, December 10, 2023
Fri, December 8, 2023
Thu, December 7, 2023

Danielle Brill Upgraded (BIIB) to Buy and Held Target at $283 on, Dec 7th, 2023


Published on 2024-10-28 07:54:15 - WOPRAI, Danielle Brill
  Print publication without navigation


Danielle Brill of Raymond James, Upgraded "Biogen Inc." (BIIB) to Buy and Held Target at $283 on, Dec 7th, 2023.

Danielle has made no other calls on BIIB in the last 4 months.



There are 12 other peers that have a rating on BIIB. Out of the 12 peers that are also analyzing BIIB, 3 agree with Danielle's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $239 on, Thursday, November 9th, 2023
  • Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $275 on, Tuesday, August 8th, 2023
  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $294 on, Tuesday, August 8th, 2023


These are the ratings of the 9 analyists that currently disagree with Danielle


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $373 on, Friday, November 10th, 2023
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $365 on, Thursday, November 9th, 2023
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $363 on, Thursday, November 9th, 2023
  • Evan Seigerman of "BMO Capital" Maintained at Buy with Decreased Target to $295 on, Thursday, November 9th, 2023
  • Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $305 on, Thursday, October 26th, 2023
  • Morten Herholdt of "HSBC" Initiated at Strong Buy and Held Target at $360 on, Wednesday, September 6th, 2023
  • Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $335 on, Monday, August 14th, 2023
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $340 on, Tuesday, August 8th, 2023
  • Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $290 on, Monday, August 7th, 2023